1315 Capital Provides Growth Financing to ProSciento
September 10, 2020
ProSciento, a San Diego–based specialty clinical research organization focused on NASH, diabetes and obesity, closed a growth financing round with healthcare investor 1315 Capital. The capital will support expansion of ProSciento's CRO operations and growth of its patient access solutions, including the NASH PASS registry.
- Buyers
- 1315 Capital
- Targets
- ProSciento, Inc.
- Industry
- Healthcare Services
- Location
- California, United States
- Transaction Type
- Growth capital
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.